These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 39275349)

  • 1. Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review.
    Sharma B; Dhiman C; Hasan GM; Shamsi A; Hassan MI
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
    Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.
    Sakunrangsit N; Ketchart W
    Eur J Pharmacol; 2020 Feb; 868():172878. PubMed ID: 31863768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8
    Jiang ZB; Xu C; Wang W; Zhang YZ; Huang JM; Xie YJ; Wang QQ; Fan XX; Yao XJ; Xie C; Wang XR; Yan PY; Ma YP; Wu QB; Leung EL
    Pharmacol Res; 2021 Jul; 169():105656. PubMed ID: 33964470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
    Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
    Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.
    Zhou ZW; Li XX; He ZX; Pan ST; Yang Y; Zhang X; Chow K; Yang T; Qiu JX; Zhou Q; Tan J; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():1511-54. PubMed ID: 25834399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
    Tripathi SK; Panda M; Biswal BK
    Food Chem Toxicol; 2019 Mar; 125():566-582. PubMed ID: 30685472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.
    Liu Y; Cai Y; He C; Chen M; Li H
    Am J Chin Med; 2017; 45(3):423-441. PubMed ID: 28359198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
    Xue D; Zhou X; Qiu J
    J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plumbagin and Its Role in Chronic Diseases.
    Panichayupakaranant P; Ahmad MI
    Adv Exp Med Biol; 2016; 929():229-246. PubMed ID: 27771927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways.
    Shi W; Fang Y; Jiang Y; Jiang S; Li Y; Li W; Xu M; Aschner M; Liu G
    Bioengineered; 2021 Dec; 12(1):4475-4488. PubMed ID: 34304701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin: A Potential Anti-cancer Compound.
    Roy A
    Mini Rev Med Chem; 2021; 21(6):731-737. PubMed ID: 33200707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proapoptotic and Growth-inhibitory Effects of Plumbagin on Human Gastric Cancer Cells Via Suppression of Signal Transducer and Activator of Transcription 3 and Protein Kinase B.
    Li J; Li J; Cai G; Shen L; Lu F
    Altern Ther Health Med; 2017 Sep; 23(5):42-48. PubMed ID: 28236621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K/Akt signaling pathway in endometrial cancer.
    Zhang X; Kan H; Liu Y; Ding W
    Food Chem Toxicol; 2021 Feb; 148():111957. PubMed ID: 33383144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma.
    Na S; Zhang J; Zhou X; Tang A; Huang D; Xu Q; Xue D; Qiu J
    Oral Dis; 2018 Sep; 24(6):920-929. PubMed ID: 29080392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Zhou SF; Qiu JX
    Drug Des Devel Ther; 2015; 9():5511-51. PubMed ID: 26491260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.
    Yin Z; Zhang J; Chen L; Guo Q; Yang B; Zhang W; Kang W
    Biomed Res Int; 2020; 2020():6940953. PubMed ID: 33344645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
    Li YC; He SM; He ZX; Li M; Yang Y; Pang JX; Zhang X; Chow K; Zhou Q; Duan W; Zhou ZW; Yang T; Huang GH; Liu A; Qiu JX; Liu JP; Zhou SF
    Cancer Lett; 2014 Mar; 344(2):239-59. PubMed ID: 24280585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.